A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/20 (2006.01) A61K 9/20 (2006.01) A61K 31/135 (2006.01) A61K 31/137 (2006.01) A61K 47/12 (2006.01) A61K 47/18 (2006.01)
Patent
CA 2168364
This application discloses a method of inhibiting degradation of the antidepressant bupropion hydrochloride in a solid pharmaceutical formulation, so that the pharmaceutical formulation will maintain at least 80 % of its initial bupropion potency after one year.
Procédé d'inhibition de la dégradation de l'hydrochlorure de bupropion antidépresseur dans une formulation pharmaceutique solide, de sorte que cette dernière conserve au moins 80 % de son pouvoir en bupropion initial au bout d'un an.
Kalidindi Sanyasi Raju
Ruff Michael David
Sutton Joel Elmore Jr.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
The Wellcome Foundation Limited
Valeant International (barbados) Srl
LandOfFree
Stabilized pharmaceutical composition containing bupropion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized pharmaceutical composition containing bupropion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized pharmaceutical composition containing bupropion will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1872758